🇺🇸 LNTH — Lantheus Holdings, Inc.

Salud Mantener
← Volver

Precio actual

101,14 USD

Máx. histórico

123,62

846 días

Caída desde máximo

-18,18%

Rango 52 semanas

50,16 – 111,86

Variación hoy

+0,34%

Cierre anterior

100,80

Rango de hoy

100,88 – 101,27

Volumen hoy

1.095.277

Peor caída histórica

-78,62%

17/08/2015 → 08/02/2016

Recuperado en 202 días

Volatilidad anualizada ⓘ

63,43%

Información
Nombre completo
Lantheus Holdings, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
1.193
PER ⓘ
24,37 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
106,99 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 12 horas
Sobre la empresa

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; LNTH-250; LNTH-2515; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; Curium Pharma; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
07/05/2021 22,14 22,65 21,90 21,97 -0,54% 3,39% 3.283.000
06/05/2021 22,25 22,29 21,76 22,09 -1,12% 2,38% 985.600
05/05/2021 23,08 23,08 22,33 22,34 -2,40% 3,25% 492.200
04/05/2021 23,83 24,26 22,75 22,89 -3,34% 6,34% 936.600
03/05/2021 23,60 24,21 23,54 23,68 -0,08% 2,82% 894.500
30/04/2021 23,27 23,80 23,26 23,70 +0,77% 2,32% 442.300
29/04/2021 23,66 23,85 23,27 23,52 -0,13% 2,45% 415.900
28/04/2021 23,01 23,70 22,75 23,55 +3,84% 4,13% 548.400
27/04/2021 22,87 23,00 22,55 22,68 -0,18% 1,99% 474.300
26/04/2021 22,28 22,82 22,27 22,72 +2,02% 2,49% 543.900
23/04/2021 21,97 22,54 21,82 22,27 +1,92% 3,28% 559.300
22/04/2021 21,62 22,11 21,02 21,85 +1,44% 5,04% 531.400
21/04/2021 20,98 21,59 20,69 21,54 +1,99% 4,29% 377.800
20/04/2021 21,12 21,31 20,70 21,12 -0,42% 2,89% 577.100
19/04/2021 21,73 21,74 21,16 21,21 -2,26% 2,67% 383.100
16/04/2021 21,75 21,97 21,52 21,70 -0,46% 2,07% 393.200
15/04/2021 21,41 21,88 21,20 21,80 +2,11% 3,18% 663.500
14/04/2021 20,90 21,56 20,80 21,35 +2,10% 3,64% 490.900
13/04/2021 21,01 21,20 20,77 20,91 -0,48% 2,03% 516.700
12/04/2021 20,76 21,16 20,41 21,01 -0,14% 3,59% 331.500
09/04/2021 21,22 21,22 20,81 21,04 -0,66% 1,93% 343.200
08/04/2021 21,10 21,61 21,03 21,18 +0,62% 2,75% 354.600
07/04/2021 21,42 21,58 20,98 21,05 -1,86% 2,80% 398.600
06/04/2021 21,38 21,77 21,32 21,45 +0,09% 2,10% 254.600
05/04/2021 21,15 21,74 21,12 21,43 +2,05% 2,96% 340.100
01/04/2021 21,35 21,51 20,70 21,00 -1,73% 3,79% 578.700
31/03/2021 21,69 21,86 21,31 21,37 -1,34% 2,54% 634.900
30/03/2021 19,81 21,99 19,72 21,66 +9,95% 11,45% 2.192.100
29/03/2021 19,63 19,93 19,52 19,70 -0,51% 2,09% 408.100
26/03/2021 20,16 20,27 19,32 19,80 -1,54% 4,71% 491.200